ibogaine has been researched along with 1-(3-chlorophenyl)piperazine in 1 studies
Studies (ibogaine) | Trials (ibogaine) | Recent Studies (post-2010) (ibogaine) | Studies (1-(3-chlorophenyl)piperazine) | Trials (1-(3-chlorophenyl)piperazine) | Recent Studies (post-2010) (1-(3-chlorophenyl)piperazine) |
---|---|---|---|---|---|
445 | 8 | 136 | 833 | 142 | 87 |
Protein | Taxonomy | ibogaine (IC50) | 1-(3-chlorophenyl)piperazine (IC50) |
---|---|---|---|
Beta-1 adrenergic receptor | Homo sapiens (human) | 2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Schechter, MD | 1 |
1 other study(ies) available for ibogaine and 1-(3-chlorophenyl)piperazine
Article | Year |
---|---|
Serotonergic mediation of fenfluramine discriminative stimuli in fawn-hooded rats.
Topics: Animals; Discrimination Learning; Dose-Response Relationship, Drug; Fenfluramine; Fluoxetine; Ibogaine; Male; Methoxydimethyltryptamines; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Quipazine; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Serotonin Receptor Agonists | 1997 |